4//SEC Filing
Guttman-McCabe Christopher 4
Accession 0001209191-22-030504
CIK 0001304492other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:19 PM ET
Size
7.6 KB
Accession
0001209191-22-030504
Insider Transaction Report
Form 4
Anterix Inc.ATEX
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
- Award
Common Stock
2022-05-17+12,655→ 68,576 total - Award
Stock Option (Right to Buy)
2022-05-17+25,511→ 25,511 totalExercise: $49.39Exp: 2032-05-17→ Common Stock (25,511 underlying)
Footnotes (2)
- [F1]Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter.
- [F2]25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.
Documents
Issuer
Anterix Inc.
CIK 0001304492
Entity typeother
Related Parties
1- filerCIK 0001828490
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:19 PM ET
- Size
- 7.6 KB